DAVID MARK
EPSTEIN
CATEDRÁTICO DE UNIVERSIDAD
Publicaciones (68) Publicaciones de DAVID MARK EPSTEIN Ver datos de investigación referenciados.
2024
-
A Systematic Review of the Impact of Spinal Cord Injury on Costs and Health-Related Quality of Life
PharmacoEconomics - Open, Vol. 8, Núm. 6, pp. 793-808
-
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system
European Journal of Health Economics
-
Public Acceptance of Measures to Control Infectious Diseases Under Different Scenarios of Severity and Transmissibility
Value in Health, Vol. 27, Núm. 5, pp. 562-569
2023
-
Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review
Value in Health, Vol. 26, Núm. 1, pp. 138-150
-
Cost-effectiveness of Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People with Diabetes
Annals of Surgery, Vol. 277, Núm. 1, pp. E184-E191
-
Cost-effectiveness of carotid endarterectomy in symptomatic patients
The British journal of surgery, Vol. 110, Núm. 2, pp. 193-199
-
Crónica del IX Taller de Evaluación Económica EEconAES
Economía y salud: boletín informativo, Núm. 101, pp. 16-17
-
Examining the benefit of graduated compression stockings in the prevention of hospital-associated venous thromboembolism in low-risk surgical patients: a multicentre cluster randomised controlled trial (PETS trial)
BMJ open, Vol. 13, Núm. 1, pp. e069802
-
INES: Interactive tool for construction and extrapolation of partitioned survival models
Cost Effectiveness and Resource Allocation, Vol. 21, Núm. 1
-
Meeting public health objectives and supporting the resumption of tourist activity through COVID-19: a triangular perspective
Current Issues in Tourism, Vol. 26, Núm. 10, pp. 1617-1634
-
Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries
Frontiers in Pharmacology, Vol. 14
-
The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease
European Journal of Health Economics, Vol. 24, Núm. 7, pp. 1033-1045
2022
-
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database
European Journal of Health Economics, Vol. 23, Núm. 9, pp. 1563-1575
-
Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice: Umbrella review
Health Policy, Vol. 126, Núm. 12, pp. 1248-1255
-
Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial
Cost Effectiveness and Resource Allocation, Vol. 20, Núm. 1
-
Cost-effectiveness analysis of current varicose veins treatments
Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 10, Núm. 2, pp. 504-513.e7
-
Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs
BMC Health Services Research, Vol. 22, Núm. 1
-
Evaluating the medical direct costs associated with prematurity during the initial hospitalization in Rwanda: a prevalence based cost of illness study
BMC Health Services Research, Vol. 22, Núm. 1
-
GACETA SANITARIA in 2021. Protecting the planet to protect health
Gaceta Sanitaria
-
How innovation can be defined, evaluated and rewarded in health technology assessment
Health Economics Review, Vol. 12, Núm. 1